Regenerative Medicine Market Driven by Geriatrics Population

Aug 10, 2019

The global regenerative medicine market size was $27 billion as of 2018, and projects the demand to grow at an impressive CAGR of 24% during the forecast period of 2019 to 2025.

Hyderabad, India - August 10, 2019 /MarketersMedia/ —

Global Regenerative Medicine Market: Demand Analysis and Growth Forecast

Loss of tissue cells and organs due to infection, ailments, and injuries encourages the market for regenerative medicines. Additionally, recent innovations of advanced nanotechnology in biomaterials have proved to be a vital growth driver in the global regenerative medicine market, as per the findings of a new business report from IndustryARC. The report evaluates that the global regenerative medicine market size was $27 billion as of 2018, and projects the demand to grow at an impressive CAGR of 24% during the forecast period of 2019 to 2025. The Regenerative Medicine Market size by Product and by Material, Regenerative Medicine Market share by top 5 companies and also the market share by start-ups during the forecast period.

Regenerative medicine is a division of translational research in molecular biology and tissue engineering which nurtures the process of replacement of human tissues, cells, and organs. According to the U.S. Government on Organ Donation and Transplantation, 36,528 transplants were performed in the year 2018, and more than 113,000 individuals are waiting in the National Transplant Waiting list for the year 2019. With such an influx of demands from the organ transplant industry, the regenerative medicines market is poised to flourish.

View Full Table of Contents of Regenerative Medicine Market:
https://www.industryarc.com/Report/16223/regenerative-medicine-market.html

Report Price (Single User): US $3850

Global Regenerative Medicine Market: Leading Segments

The regenerative medicines market is growing throughout the developing and developed economies. However, as per the Industry ARC’s report, the North American region is the most profitable region, offering around 30% to 32% of the total demand in 2018. Being a developed segment of the world, the North American population possess a significant amount of disposable income. This economic freedom has enabled the population to pursue an expensive and effective therapy in case of any tissue or organ damage.

Orthopaedic and musculoskeletal are the most lucrative application segments of the regenerative medicines market, increasing at a striking CAGR of 21% to 23% through the aforementioned forecast period. The globally rising geriatrics population is facing issues related to deformities of bones and muscles. With increasing number of facilities for the treatment of orthopaedic and musculoskeletal damages, the regeneration market is projected to grow vigorously.

Global Regenerative Medicine Market Trends

The Density of population affected by instances of damaged skin and skin cancer has risen in recent years. The introduction of skin drafting methodology with the help of regenerative medicines has facilitated a large pool of the population. Skin drafting allows the small molecules and biologics of the damaged skin cells to produce fresh neural stem cells in the skin thereby curing the affected area. The consistently increasing awareness towards positive skin healthcare is subjected to drive growth in the regenerative medicine market.

The regenerative medicine market has immensely affected the lives of differently abled individuals. The deformation of limbs among the physically challenged personalities is effectively being cured with the employment of regenerative medicines. With regular innovations in the nanotechnology for biomedical, the regenerative medicines is expected to optimize the circumstances aroused due to natural or human error incidents.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=16223

Global Regenerative Medicine Market: Competitive Landscape

Some of the key companies identified in the report that are currently holding majority shares in the global regenerative medicine market are: Vertex Pharmaceuticals Incorporated, Medtronic Plc, Allegan Plc, Smith & Nephew Plc, Nuvasive, Inc, Cytori Therapeutics, Inc, Vericel Corporation, BlueRock Therapeutics, Octane Biotech Inc, and Theracell Advanced Biotechnology Ltd.

Related Reports:

A. Cartilage Repair/ Cartilage Regeneration Market
https://www.industryarc.com/Report/16714/cartilage-repair-cartilage-regeneration-market.html

B. Synthetic Biology Market
https://www.industryarc.com/Report/15142/synthetic-biology-market.html

About IndustryARC:

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: +1-614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Source URL: https://marketersmedia.com/regenerative-medicine-market-driven-by-geriatrics-population/88906412

Source: MarketersMedia

Release ID: 88906412

More News

GISBH: KPWKM prioritises swift reunification of rescued children with families

GISBH: KPWKM prioritises swift reunification of rescued children with families

Oct 15, 2024

KUALA LUMPUR: The immediate return of children rescued during Op Global to their parents and families is a top priority for the Ministry of Women, Family and Community Development (KPWKM). However, its minister, Datuk Seri Nancy Shukri said KPWKM must first ensure that the children’s parents and families can provide adequate and proper care. “For cases where the capability of the parents and families is clearly established, the reunification process can proceed without delay. In more complex situations, intervention programmes will be implemented to ensure the children’s and families’ best interests are safeguarded “The ultimate goal is to reunite these children with their families. However, before this can happen, several factors need to be carefully evaluated. This is not about denying anyone’s rights, but about ensuring the best interests of the children are upheld,” Nancy said during a minister’s briefing session on GISB Holdings Sdn Bhd (GISBH) in the Dewan Rakyat today. As of yesterday, 560 children – 283 boys and 277 girls – had been placed in safe custody after the Social Welfare Department (JKM) obtained a temporary court custody order for two months under Section 25(2)(a) of the Child Act 2001. Meanwhile, Nancy said the Task Force Profiling Team for Op Global found that 94.3 per cent of the 558 profiled children had at least one living biological parent, while 5.7 per cent had no parents or no available information on their parents. Health assessments showed that 51.6 per cent of the children were underweight, falling below the healthy Body Mass Index (BMI), while 46.1 per cent had a normal weight and the remaining children were classified as obese, she added. “Three children have been issued persons with disabilities (PwD) cards, while 27 others display symptoms of disability,” she added. Cognitive assessments were also conducted on 385 children aged seven and above, with 71.9 per cent (277 children) showing no signs of cognitive disorders, she said. “However, 20.26 per cent (78 children) displayed moderate cognitive disorders, while 7.79 per cent (30 children) were found to have severe cognitive impairments,” Nancy said.

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Oct 15, 2024

PETALING JAYA: A surprise inspection by Johor Public Works, Transport, Infrastructure, and Communications committee chairman, Mohamad Fazli Mohamad Salleh recently found 17 Immigration counters at the Johor checkpoint empty. The inspection was conducted following a video circulating online showing the 17 empty counters at the checkpoint in Sultan Abu Bakar Complex (KSAB), triggering public backlash. He confirmed that the surprise inspection found that the incident actually occurred, Harian Metro reported. The video showed the empty counters, with green lights on however, the pathways were closed off to commuters. ALSO READ: Woman calls out Immigration officer for alleged rude behaviour Fazli then instructed that the green lights to be turned off to indicate that the lane is closed, to ensure no one is confused. “If there is no solid reason given regarding the incident, this can be considered intentional,” he was quoted as saying. On the other hand, Johor Immigration director Datuk Mohd Rusdi Mohd Darus said an internal probe will be conducted on the incident. ALSO READ: Woman expresses gratitude to Johor Immigration officers for returning lost RM1.5k “The internal investigation will determine whether the immigration officer handling the counter neglected their duties or intentionally left the counter without permission. “We will not tolerate this behaviour, and strict disciplinary action will be taken against them if they are found to have neglected their duties. “It is a violation of responsibility, and I take this issue seriously,“ he was quoted as saying.

Malaysia should seize opportunity in global medical devices market - Chang

Malaysia should seize opportunity in global medical devices market - Chang

Oct 15, 2024

KUALA LUMPUR: Malaysian innovators and manufacturers should seize the opportunity to tap into the immense potential of the global medical devices industry, which is projected to reach nearly US$800 billion by 2030, says Science, Technology and Innovation (MOSTI) Minister Chang Lih Kang. Chang noted that Malaysia had many high-quality products and innovators in the medical devices sector, with the government continuously encouraging and supporting industry players in research and development (R&D) and commercialisation efforts. “The market is vast, and we have plenty of room for success. To support R&D, of course, not limited to the medical devices industry, MOSTI offers various funding facilities, grants, matching grants, and equity where we invest in relevant startups,” he said. Chang said this to reporters after officiating the soft launch of INNOMed: Innovation Pitching Powered by PERANTIM, a key event in the International Medical Device Exhibition & Conference (IMDEC) 2024. Also present were Medical Device Authority (MDA) chief executive officer Dr P. Muralitharan, Malaysia Medical Devices Manufacturers Association (PERANTIM) president Johari Abu Kasim, and organising chairman of INNOMed, Dr Hyzan Mohd Yusof. Earlier in his speech, Chang said that under Malaysia’s New Industrial Master Plan (NIMP) 2030, the government aimed to foster synergies between the manufacturing and engineering sectors and the medical devices sector. This includes creating advanced inspection tools, solutions for imaging and endoscopy, implantable devices, and minimally invasive surgical tools. Meanwhile, Muralitharan told Bernama that, according to figures from the Department of Statistics Malaysia (DOSM), Malaysia’s total trade in medical devices, valued at RM25.61 billion from January to July this year, increased by 23.5 per cent compared to the same period in 2023 (RM20.74 billion). He added that the export of medical devices was valued at RM20.15 billion, an increase of 25.7 per cent compared to RM16.02 billion in 2023. In his speech, Dr Hyzan said that medical device innovation presented an opportunity to improve healthcare while boosting the economy, with the industry projected to reach nearly US$2 billion by 2025, making it one of the fastest-growing sectors. “By focusing on innovation, we can create high-skilled jobs, reduce our dependence on imported technologies, and position Malaysia as a global leader. Last year, we spent US$5 billion on medical devices, with 95 per cent being imports. Our goal is to reduce this to 50 per cent within five years,” he said. He also emphasised that close collaboration among universities, innovators, manufacturers, clinicians, and government agencies was key to ensuring that ideas and research transitioned smoothly from laboratories to clinical applications and into the hands of healthcare providers. INNOMed, themed “Unleashing the Power of Medical Technology: Shaping the Future of Healthcare,“ is organised by the MDA and will take place from Dec 10 to 12 at the Kuala Lumpur Convention Centre (KLCC).

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Utara Selatan

Bringing you from Utara to Selatan, we publish travel guides to make sure you will discover new places to visit in Malaysia and try all the local delicacies.

Newsletter